Off-label use: notification by laboratories 2 May 2022 All news France_20220314-demarche-usagenonconforme-guide-entreprises-exploitant-specialites-pharmaceutiques-fevrier-2022_Mar2022-2Télécharger
List of medicines under additional monitoring 29 April 2022 All news EU-List-of-medicines-under-additional-monitoring-_-summary-of-changes_Apr2022-1Télécharger
(China) Key Points for Pharmacovigilance Inspections 25 April 2022 All news https://baipharm.chemlinked.com/news/china-nmpa-announces-key-points-for-pharmacovigilance-inspections
( Spain)Directory of Competent Bodies in matters of Pharmacovigilance of the Autonomous Communities and of the AEMPS 22 April 2022 All news Spain-Directory-of-Competent-Bodies-in-matters-of-Pharmacovigilance-of-the-Autonomous-Communities-and-of-the-AEMPS_04Apr2022-2Télécharger
E2B(R3) Individual Case Safety Report (ICSR) Specification and Related Files 19 April 2022 All news https://www.ich.org/page/e2br3-individual-case-safety-report-icsr-specification-and-related-files
CLINICAL TRIALS REGULATION (EU) NO 536/2014 – QUESTIONS&ANSWERS VERSION 6 15 April 2022 All news EU-regulation-536-2014-QA_version-6_Apr2022-1Télécharger
New EU regulation on clinical trials of medicinal products 11 April 2022 All news https://ansm.sante.fr/actualites/entree-en-application-du-nouveau-reglement-europeen-relatif-aux-essais-cliniques-des-medicaments
Reporting safety information on clinical trials 8 April 2022 All news https://www.ema.europa.eu/en/human-regulatory/research-development/clinical-trials/reporting-safety-information-clinical-trials
List of medicines under additional monitoring 4 April 2022 All news https://www.ema.europa.eu/en/human-regulatory/post-authorisation/pharmacovigilance/medicines-under-additional-monitoring/list-medicines-under-additional-monitoring
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 06-09 April 2022 31 March 2022 All news https://www.ema.europa.eu/en/documents/minutes/minutes-prac-meeting-6-9-april-2021_en.pdf
